Aetna Stock Price, News & Analysis (NYSE:AET)

$179.70 1.21 (0.68 %)
(As of 12/17/2017 04:00 PM ET)
Previous Close$179.70
Today's Range$178.16 - $180.62
52-Week Range$116.04 - $192.37
Volume5.28 million shs
Average Volume4.01 million shs
Market Capitalization$58.60 billion
P/E Ratio17.6
Dividend Yield1.11%
Beta0.61

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Receive AET News and Ratings via Email

Sign-up to receive the latest news and ratings for AET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorHealthcare
SymbolNYSE:AET
CUSIP00817Y10
Phone+1-860-2730123

Debt

Debt-to-Equity Ratio0.52%
Current Ratio0.53%
Quick Ratio0.53%

Price-To-Earnings

Trailing P/E Ratio17.6
Forward P/E Ratio18.37
P/E Growth1.64

Sales & Book Value

Annual Sales$63.16 billion
Price / Sales0.93
Cash Flow$10.45 per share
Price / Cash17.20
Book Value$51.13 per share
Price / Book3.51

Profitability

Trailing EPS$5.41
Net Income$2.27 billion
Net Margins2.93%
Return on Equity21.84%
Return on Assets5.80%

Miscellaneous

Employees49,500
Outstanding Shares326,170,000

Aetna (NYSE:AET) Frequently Asked Questions

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Monday, December 4th. Shareholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share on Friday, January 26th. This represents a $2.00 annualized dividend and a yield of 1.11%. The ex-dividend date is Wednesday, January 10th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna announced that its Board of Directors has initiated a share repurchase plan on Friday, April 7th 2017, which permits the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 98% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc (NYSE:AET) announced its earnings results on Tuesday, October, 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to analysts' expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business's revenue was down 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.07 EPS. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, January, 30th 2018. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna updated its FY17 earnings guidance on Tuesday, October, 31st. The company provided EPS guidance of ~$9.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.56.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

21 equities research analysts have issued 1-year price objectives for Aetna's shares. Their forecasts range from $135.00 to $208.00. On average, they anticipate Aetna's stock price to reach $178.71 in the next twelve months. View Analyst Ratings for Aetna.

What are Wall Street analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer (Age 60)
  • Karen S. Lynch, President (Age 54)
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer (Age 53)
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel (Age 58)
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services (Age 56)
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology (Age 63)
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Francis S. Soistman Jr., Executive Vice President - Government Services (Age 60)
  • Heather Dixon, Chief Accounting Officer, Vice President, Controller (Age 45)
  • Edward J. Ludwig, Lead Independent Director (Age 65)

Who owns Aetna stock?

Aetna's stock is owned by a number of of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (1.35%), Bank of New York Mellon Corp (1.31%), Davis Selected Advisers (1.17%), Dimensional Fund Advisors LP (1.13%), Ameriprise Financial Inc. (0.73%) and Legal & General Group Plc (0.56%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., Capital International Investors, APG Asset Management N.V., Principal Financial Group Inc., Davis Selected Advisers, Dimensional Fund Advisors LP, State of Tennessee Treasury Department and Cohen & Steers Inc.. Company insiders that have sold Aetna company stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was bought by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Point72 Asset Management L.P., Ardevora Asset Management LLP, Stifel Financial Corp, KBC Group NV, Caisse DE Depot ET Placement DU Quebec, Canada Pension Plan Investment Board and New York State Common Retirement Fund. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $179.70.

How big of a company is Aetna?

Aetna has a market capitalization of $58.60 billion and generates $63.16 billion in revenue each year. The company earns $2.27 billion in net income (profit) each year or $5.41 on an earnings per share basis. Aetna employs 49,500 workers across the globe.

How can I contact Aetna?

Aetna's mailing address is 151 Farmington Ave, HARTFORD, CT 06156-0001, United States. The company can be reached via phone at +1-860-2730123 or via email at [email protected]


MarketBeat Community Rating for Aetna (AET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  674 (Vote Outperform)
Underperform Votes:  439 (Vote Underperform)
Total Votes:  1,113
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aetna (NYSE:AET) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.582.632.742.71
Ratings Breakdown: 0 Sell Rating(s)
10 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $170.81$167.90$156.79$145.80
Price Target Upside: 4.41% downside1.91% downside3.93% downside2.35% downside

Aetna (NYSE:AET) Consensus Price Target History

Price Target History for Aetna (NYSE:AET)

Aetna (NYSE:AET) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2017Credit Suisse GroupReiterated RatingNeutral$174.00 -> $195.00LowView Rating Details
12/6/2017ArgusDowngradeBuy -> Hold$185.00LowView Rating Details
12/4/2017Wells Fargo & CompanyReiterated RatingOutperform$200.00 -> $208.00HighView Rating Details
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$187.00N/AView Rating Details
11/3/2017Raymond James FinancialUpgradeMarket Perform -> Outperform$200.00N/AView Rating Details
11/2/2017CitigroupBoost Price TargetBuy$183.00 -> $197.00N/AView Rating Details
11/1/2017Jefferies GroupBoost Price TargetHold$165.00 -> $185.00N/AView Rating Details
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 -> $200.00N/AView Rating Details
10/26/2017Cantor FitzgeraldDowngradeOverweight -> NeutralN/AView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 -> $179.00LowView Rating Details
8/7/2017Deutsche BankBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
5/27/2017CowenSet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of AmericaReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017BarclaysReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017OppenheimerReiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
(Data available from 12/17/2015 forward)

Earnings

Aetna (NYSE:AET) Earnings History and Estimates Chart

Earnings by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018N/AView Earnings Details
10/31/2017Q3 2017$2.06$2.45$15.12 billion$14.99 billionViewN/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Aetna (NYSE:AET) Earnings Estimates

2017 EPS Consensus Estimate: $8.20
2018 EPS Consensus Estimate: $9.95
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.08$2.42$2.17
Q4 20174$1.15$1.74$1.35
Q1 20181$2.75$2.75$2.75
Q2 20182$2.62$2.82$2.72
Q3 20182$2.60$2.67$2.64
Q4 20181$1.84$1.84$1.84
(Data provided by Zacks Investment Research)

Dividends

Aetna (NYSE:AET) Dividend Information

Next Dividend:1/26/2018
Annual Dividend:$2.00
Dividend Yield:1.11%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:36.97% (Trailing 12 Months of Earnings)
20.45% (Based on This Year's Estimates)
19.82% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/4/2017quarterly$0.501.12%1/10/20181/11/20181/26/2018
9/29/2017quarterly$0.501.25%10/11/201710/12/201710/27/2017
5/19/2017quarterly$0.501.42%7/11/20177/13/20177/28/2017
2/17/2017quarterly$0.501.58%4/11/20174/13/20174/28/2017
12/2/2016quarterly$0.250.77%1/10/20171/12/20171/27/2017
9/30/2016quarterly$0.250.87%10/11/201610/13/201610/28/2016
5/20/2016quarterly$0.250.91%7/12/20167/14/20167/29/2016
2/19/2016quarterly$0.250.94%4/12/20164/14/20164/29/2016
12/4/2015quarterly$0.250.97%1/12/20161/14/20161/29/2016
9/25/2015quarterly$0.250.95%10/13/201510/15/201510/30/2015
5/15/2015quarterly$0.250.88%7/14/20157/16/20157/31/2015
2/27/2015quarterly$0.251%4/7/20154/9/20154/24/2015
11/21/2014quarterly$0.251.15%1/13/20151/15/20151/30/2015
9/19/2014quarterly$0.231.08%10/14/201410/16/201410/31/2014
5/30/2014quarterly$0.231.16%7/8/20147/10/20147/25/2014
2/28/2014quarterly$0.231.25%4/8/20144/10/20144/25/2014
12/6/2013quarterly$0.231.35%1/14/20141/16/20141/31/2014
9/27/2013quarterly$0.201.25%10/8/201310/10/201310/25/2013
5/17/2013quarterly$0.201.35%7/9/20136/11/20137/26/2013
2/19/2013quarterly$0.201.66%4/9/20134/11/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Aetna (NYSE AET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 88.01%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.61View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.80View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aetna (NYSE AET) News Headlines

Source:
DateHeadline
U.S. employers say CVS-Aetna deal would affect health-benefits ... - ReutersU.S. employers say CVS-Aetna deal would affect health-benefits ... - Reuters
www.reuters.com - December 17 at 3:21 PM
Aetna Inc (AET) Expected to Post Quarterly Sales of $14.89 BillionAetna Inc (AET) Expected to Post Quarterly Sales of $14.89 Billion
www.americanbankingnews.com - December 15 at 6:24 AM
Form 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JRForm 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JR
www.streetinsider.com - December 14 at 3:22 PM
How a CVS-Aetna merger could change the health care scene in LouisvilleHow a CVS-Aetna merger could change the health care scene in Louisville
www.bizjournals.com - December 14 at 3:22 PM
Aetna Inc (AET) Expected to Post Earnings of $1.18 Per ShareAetna Inc (AET) Expected to Post Earnings of $1.18 Per Share
www.americanbankingnews.com - December 13 at 3:53 PM
Ascension, Providence St. Joseph in talks for mergerAscension, Providence St. Joseph in talks for merger
finance.yahoo.com - December 13 at 3:23 PM
CVS-Aetna Deal Leading A Wave of Change In The Hospital SectorCVS-Aetna Deal Leading A Wave of Change In The Hospital Sector
feeds.benzinga.com - December 13 at 2:35 PM
CVS-Aetna Deal Leading a Wave of Change in Hospital Sector - NasdaqCVS-Aetna Deal Leading a Wave of Change in Hospital Sector - Nasdaq
www.nasdaq.com - December 13 at 7:11 AM
CVS-Aetna Deal Leading a Wave of Change in Hospital SectorCVS-Aetna Deal Leading a Wave of Change in Hospital Sector
finance.yahoo.com - December 13 at 7:11 AM
CVS & AETNA: Are The Risks Worth The Rewards? - Seeking AlphaCVS & AETNA: Are The Risks Worth The Rewards? - Seeking Alpha
seekingalpha.com - December 12 at 7:38 AM
CVS expects Justice Department to handle review of Aetna deal - ReutersCVS expects Justice Department to handle review of Aetna deal - Reuters
www.reuters.com - December 10 at 7:13 AM
Aetna Inc. (AET) Expected to Earn FY2019 Earnings of $11.00 Per ShareAetna Inc. (AET) Expected to Earn FY2019 Earnings of $11.00 Per Share
www.americanbankingnews.com - December 8 at 6:36 PM
CVS Expects DOJ To Handle Review Of Aetna DealCVS Expects DOJ To Handle Review Of Aetna Deal
www.msn.com - December 8 at 3:21 PM
Discount Retail Stocks, LULU Earnings, & Healthcare ConsolidationDiscount Retail Stocks, LULU Earnings, & Healthcare Consolidation
finance.yahoo.com - December 8 at 3:21 PM
Will CVS Get the Chance to Buy Aetna?Will CVS Get the Chance to Buy Aetna?
www.fool.com - December 7 at 11:07 PM
CVS-Aetna deal could expedite a possible Humana mergerCVS-Aetna deal could expedite a possible Humana merger
www.bizjournals.com - December 7 at 3:23 PM
A.M. Best Places Credit Ratings of Aetna Inc. and Its Insurance Subsidiaries Under Review With Negative ImplicationsA.M. Best Places Credit Ratings of Aetna Inc. and Its Insurance Subsidiaries Under Review With Negative Implications
finance.yahoo.com - December 7 at 3:23 PM
RMF Euro CDO V plc -- Moodys assigns Chloe B2 CFR, B2 first-lien debtRMF Euro CDO V plc -- Moody's assigns Chloe B2 CFR, B2 first-lien debt
finance.yahoo.com - December 7 at 3:23 PM
CVS’s $68 Billion Bid to Bring One-Stop Shopping to Health CareCVS’s $68 Billion Bid to Bring One-Stop Shopping to Health Care
finance.yahoo.com - December 7 at 3:23 PM
AM Best Places Credit Ratings of Aetna Inc. and Its Insurance Subsidiaries Under Review With Negative Implications - Business Wire (press release)AM Best Places Credit Ratings of Aetna Inc. and Its Insurance Subsidiaries Under Review With Negative Implications - Business Wire (press release)
www.businesswire.com - December 7 at 7:27 AM
Aetna Inc. Forecasted to Earn FY2018 Earnings of $9.90 Per Share (AET)Aetna Inc. Forecasted to Earn FY2018 Earnings of $9.90 Per Share (AET)
www.americanbankingnews.com - December 6 at 4:00 PM
UnitedHealths Splish Beats CVS-Aetnas Splash - BloombergUnitedHealth's Splish Beats CVS-Aetna's Splash - Bloomberg
www.bloomberg.com - December 6 at 3:22 PM
UnitedHealth ventures deeper into care with nearly $5B dealUnitedHealth ventures deeper into care with nearly $5B deal
marketbeat.com - December 6 at 1:33 PM
Top-End Analytics for Earnings Visibility Keep Aetna (AET) a Strong BuyTop-End Analytics for Earnings Visibility Keep Aetna (AET) a Strong Buy
investorplace.com - December 6 at 12:10 PM
Argus Lowers Aetna (AET) to HoldArgus Lowers Aetna (AET) to Hold
www.americanbankingnews.com - December 6 at 9:46 AM
Aetna (AET) Receives "Neutral" Rating from Credit Suisse GroupAetna (AET) Receives "Neutral" Rating from Credit Suisse Group
www.americanbankingnews.com - December 6 at 9:02 AM
CVS Drops The Acquisition Bombshell - Aetna, Inc. (NYSE:AET ... - Seeking AlphaCVS Drops The Acquisition Bombshell - Aetna, Inc. (NYSE:AET ... - Seeking Alpha
seekingalpha.com - December 6 at 7:43 AM
The CVS-Aetna Deal Is Leaving Wall Street Skeptical | Fortune - FortuneThe CVS-Aetna Deal Is Leaving Wall Street Skeptical | Fortune - Fortune
fortune.com - December 6 at 7:43 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates the Acquisition of Aetna Inc. - PR Newswire (press release)SHAREHOLDER ALERT: WeissLaw LLP Investigates the Acquisition of Aetna Inc. - PR Newswire (press release)
www.prnewswire.com - December 6 at 7:43 AM
CVSs Aetna Takeover Comes With a $2.1 Billion Termination Fee - BloombergCVS's Aetna Takeover Comes With a $2.1 Billion Termination Fee - Bloomberg
www.bloomberg.com - December 6 at 7:43 AM
CVS Boss Larry Merlo’s Path From Corner Pharmacy to C-SuiteCVS Boss Larry Merlo’s Path From Corner Pharmacy to C-Suite
finance.yahoo.com - December 6 at 7:43 AM
WSJ: Outgoing Aetna CEO Bertolini set to reap ~$500M if CVS deal closesWSJ: Outgoing Aetna CEO Bertolini set to reap ~$500M if CVS deal closes
seekingalpha.com - December 5 at 6:19 PM
Aetna CEO Bertolini could exit after CVS deal with $500 millionAetna CEO Bertolini could exit after CVS deal with $500 million
www.marketwatch.com - December 5 at 3:22 PM
Aetnas CEO Set to Reap About $500 Million if CVS Deal ClosesAetna's CEO Set to Reap About $500 Million if CVS Deal Closes
www.msn.com - December 5 at 3:22 PM
See what the IHS Markit Score report has to say about Aetna Inc.See what the IHS Markit Score report has to say about Aetna Inc.
finance.yahoo.com - December 5 at 3:22 PM
Why CVS/Aetna Could Be a Game Changer -- And Whos Next May Surprise YouWhy CVS/Aetna Could Be a Game Changer -- And Who's Next May Surprise You
finance.yahoo.com - December 5 at 3:22 PM
ICYMI: Street Reacts To CVS-Aetna, A Crypto Plays New Investment, And Other Top StoriesICYMI: Street Reacts To CVS-Aetna, A Crypto Play's New Investment, And Other Top Stories
feeds.benzinga.com - December 5 at 8:51 AM
Aetna (AET) Earns Outperform Rating from Wells Fargo & CompanyAetna (AET) Earns Outperform Rating from Wells Fargo & Company
www.americanbankingnews.com - December 4 at 7:32 PM
AETNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aetna Inc. - AETAETNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aetna Inc. - AET
www.prnewswire.com - December 4 at 7:25 PM
What Wall Street Thinks Of The $69 Billion CVS-Aetna DealWhat Wall Street Thinks Of The $69 Billion CVS-Aetna Deal
feeds.benzinga.com - December 4 at 7:24 PM
$69 Billion Mega-Deal: What CVS Healths Acquisition of Aetna Means for Investors$69 Billion Mega-Deal: What CVS Health's Acquisition of Aetna Means for Investors
www.fool.com - December 4 at 4:27 PM
Why CVS Health Is Sinking TodayWhy CVS Health Is Sinking Today
www.fool.com - December 4 at 4:27 PM
Less choice, higher prices feared in CVS takeover of health insurer AetnaLess choice, higher prices feared in CVS' takeover of health insurer Aetna
www.latimes.com - December 4 at 3:39 PM
AETNA INC. SHAREHOLDER ALERT: Rigrodsky & Long, PA Announces Investigation of Buyout - Business Wire (press release)AETNA INC. SHAREHOLDER ALERT: Rigrodsky & Long, PA Announces Investigation of Buyout - Business Wire (press release)
www.businesswire.com - December 4 at 3:22 PM
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aetna Inc. - PR Newswire (press release)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aetna Inc. - PR Newswire (press release)
www.prnewswire.com - December 4 at 3:22 PM
CVS, Aetna executives defend $69 billion deal to sceptical Wall StreetCVS, Aetna executives defend $69 billion deal to sceptical Wall Street
finance.yahoo.com - December 4 at 3:22 PM
AETNA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BuyoutAETNA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
finance.yahoo.com - December 4 at 3:22 PM
Wall Street Opens StrongWall Street Opens Strong
finance.yahoo.com - December 4 at 3:22 PM
3 Reasons Why Aetna Isnt Up 14% Today3 Reasons Why Aetna Isn't Up 14% Today
www.fool.com - December 4 at 2:51 PM
Analyst Lays Out Pros, Cons Of The CVS-Aetna DealAnalyst Lays Out Pros, Cons Of The CVS-Aetna Deal
feeds.benzinga.com - December 4 at 12:50 PM

SEC Filings

Aetna (NYSE:AET) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aetna (NYSE AET) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.